Stocks
Clover Health Investments (CLOV) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -38.7% | -23.0% | -16.5% | -3.28% | -4.36% | -2.50% | ||
| Changes by years, y/y, % | -27pp | +16pp | +7pp | +13pp | -1pp | -17.9% | |||
Clover Health Investments. EBITDA margin, %
Clover Health Investments. EBITDA margin, changes, pp
Clover Health Investments (CLOV) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | -4.83% | -10.0% | 3.72% | 3.84% | 3.84% | -2.50% | |
| Changes by years, y/y, % | -2pp | -4pp | +4pp | +6pp | +6pp | |||
| Changes by quarters, q/q, % | -3pp | -5pp | +14pp | +0pp | 0pp | |||
